Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
People still recovering I think... lol
Slow day
Company President, Eric Willis, stated, "We are delighted to take delivery of these first HeartSentry human-use units from our manufacturer. The design and production team have worked for nine months to perfect the HeartSentry technology and device design, and we have achieved a significant milestone by moving the HeartSentry out of the lab and into a hand-held mobile unit ready for clinical trials. We look forward to being able to commence study enrollment in our upcoming HeartSentry clinical study in order to gather the foundational dataset aimed at supporting FDA clearance."
GREAT OPPORTUNITY HERE...Global revenues for the medical device market are already a multi-billion dollar industry and the sector aims to continue its growth through leverage created through mergers and acquisitions, as well as the development of new products with improved efficiency. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as spine disorders, diabetes, and cardiovascular diseases, are expected to drive the market growth. In terms of application, the cardiovascular segment is expected to register the highest CAGR. The medical device sector as a whole has long been one of the more lucrative markets in the overall healthcare industry, as technology and research have propelled the market to new heights. With the rising influence of technology, the players in the medical device market are constantly diversifying and include some big tech names as of late. Active healthcare companies today with current developments include: Lexington Biosciences, Inc. (CNSX:LNB.CN) (OTC:LXGTF), Immunomedics Inc. (NASDAQ:IMMU), Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), BioTelemetry Inc. (NASDAQ:BEAT), VistaGen Therapeutics Inc. (NASDAQ:VTGN).
Well said Blockchain... true
Agrelets finish it green
Good fellings hahaha
Come on, closing green, good beginning of the year
That's what I am asking for, green +2% lets break the 50s finaly
Green +13% is a good start of the year lol
Good day and year to everybody!
Morning Mike, yes the year of victory!
LXGTF Management Dream Team: https://lexingtonbiosciences.com/company/management/
Exactly SuperPac, I wish you a happy and blessed New Year with many business victories :)
LXGTF Article by Jonathan Maltz, "What is Endothelial Function..." : https://lexingtonbiosciences.com/news/endothelial-function-important-health/
LXGTF Article by Jonathan Maltz, "What is Endothelial Function..." : https://lexingtonbiosciences.com/news/endothelial-function-important-health/
A MUST WATCH LXGTF video: https://vimeo.com/183611304
GOOD ARTICLE RECENTLY RELEASED
https://insiderfinancial.com/lexington-bioscien-otcmktslxgtf-venturing-into-fortune-500-territory
LXGTF is a "Breakthrough technology", a real understatement. In LXGTF HeartSentry you have a simple, affordable, portable device that requires no expert training to use and yet by measuring endothelial function it can knock the wind out of the diseases that cause 25% of ALL deaths in the modern world (heart disease and stroke)Its only competition area devices that cost up to six figures, can fill a small room and require medical training to operate.
NEW TO LXGTF? NEED SOME READING MATERIAL??
START DD HERE:
https://lexingtonbiosciences.com/wp-content/uploads/2017/10/Lexington-Website-Presentation.pdf
Good morning friends and HAPPY NEW YEAR, the YEAR of LXGTF launching rocket!
Just a new year relaxed period
First of the session
Yep same to you Blockchain
I am expecting it.
Yep the volume is small today, people are already in champagne preparations.
The management is amazing
I think that we will here many great updates in between with some unknown info yet.
Is good that we know zhe correct calculation here
Can we close here green today?
I see things are moving well!
Come on +14,65%, love the last green week!
will be remembered as the year when the legend started :)
OH yes I think is time now!
ADAC green +28,9% NOW! Check ADAC...
we have a surprise every few days, all the fake criticism cannot do anything to a real story!
What a great green 28,9%, awesome
Good morning everybody!
LXGTF SOLUTION: EARLY DETECTION
The only way to detect that arteries are vulnerable to
atherosclerosis is to assess endothelial function. This is a
test of the endothelial cells that line all the arteries in the body.
The endothelium is the single layer of cells that line various
organs and cavities, especially the heart, blood and lymphatic
vessels. These cells act as a shield, preventing plaque from
forming inside the artery wall, and produce substances that
stop blood clots from developing in the vessel.
Healthy endothelial cells release nitric oxide (NO), which
is responsible for most of the protective functions of these
cells in the artery.
In an at-risk individual, the endothelial cells do not
produce enough NO, or the NO produced is deactivated
by chemicals in the bloodstream before it can prevent
deposits from forming in the arterial wall.